Noevir Holdings Co., Ltd.
FY2026 Q3 Financial Summary (Consolidated) [Japanese GAAP]
Disclosure of the overview of the consolidated results for the third quarter of the FY2026. Includes notes on trends in net sales and profits by segment, changes in financial position, movements in net assets and equity ratio, and outlook.
Key Figures
- Net sales: Unknown
- Operating income: Unknown
- Total net assets: Unknown
- Equity ratio: 69.4% (Note)
- Total tangible fixed assets: Unknown
AI要約
Overview of Operating Results
A summary of the trends in net sales and segment profits for the cumulative third quarter, the impact of supply and demand conditions, and movements in costs and expenses. Includes notes showing contributions to net sales and profits by cosmetics, pharmaceuticals, and other segments, and trends across segments.
Overview of Financial Position / Cash, etc.
Information provided on total assets, net assets, and equity ratio trends, breakdown of current and non-current assets, cash and deposits status, and liabilities composition (current vs. non-current), along with notes on cash flows.
Noevia Holdings
Company overview · Stock price · Financial data · All IR
